Qualigen Therapeutics Inc (QLGN)
3.928
-0.36
(-8.43%)
USD |
NASDAQ |
Nov 12, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Qualigen Therapeutics Price: 3.928 for Nov. 12, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 12, 2024 | 4.33 | 4.50 | 3.89 | 3.928 | 51081.00 |
Nov 11, 2024 | 4.78 | 4.90 | 4.225 | 4.29 | 117407.0 |
Nov 08, 2024 | 4.50 | 4.85 | 4.31 | 4.77 | 103581.0 |
Nov 07, 2024 | 4.70 | 4.90 | 4.16 | 4.53 | 78713.00 |
Nov 06, 2024 | 5.00 | 5.008 | 4.601 | 4.69 | 84083.00 |
Nov 05, 2024 | 4.56 | 5.144 | 4.26 | 5.08 | 278837.0 |
Nov 04, 2024 | 4.945 | 5.965 | 4.26 | 5.055 | 134465.0 |
Nov 01, 2024 | 5.00 | 5.20 | 4.69 | 4.92 | 54468.00 |
Oct 31, 2024 | 5.005 | 5.305 | 4.625 | 4.93 | 32794.00 |
Oct 30, 2024 | 5.24 | 5.30 | 5.005 | 5.145 | 41435.00 |
Oct 29, 2024 | 5.40 | 5.50 | 5.145 | 5.25 | 53975.00 |
Oct 28, 2024 | 6.00 | 6.75 | 5.105 | 5.61 | 224282.0 |
Oct 25, 2024 | 5.69 | 10.45 | 5.50 | 6.075 | 1.043M |
Oct 24, 2024 | 9.52 | 10.00 | 3.752 | 5.405 | 1.691M |
Oct 23, 2024 | 8.93 | 9.745 | 8.50 | 8.70 | 197225.0 |
Oct 22, 2024 | 8.85 | 9.08 | 8.62 | 8.84 | 3675.00 |
Oct 21, 2024 | 8.50 | 9.125 | 8.188 | 9.125 | 8953.00 |
Oct 18, 2024 | 7.875 | 8.50 | 7.875 | 8.36 | 2160.00 |
Oct 17, 2024 | 8.155 | 8.335 | 8.005 | 8.01 | 1350.00 |
Oct 16, 2024 | 8.45 | 8.45 | 7.955 | 8.055 | 7635.00 |
Oct 15, 2024 | 8.50 | 8.50 | 8.03 | 8.145 | 1743.00 |
Oct 14, 2024 | 8.395 | 8.645 | 8.065 | 8.42 | 1079.00 |
Oct 11, 2024 | 8.00 | 8.67 | 8.00 | 8.395 | 3640.00 |
Oct 10, 2024 | 8.00 | 8.47 | 7.875 | 8.47 | 1662.00 |
Oct 09, 2024 | 8.45 | 8.478 | 7.875 | 8.00 | 6215.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.928
Minimum
Nov 12 2024
9025.00
Maximum
May 12 2020
907.74
Average
285.45
Median
Price Benchmarks
CEL-SCI Corp | 0.7007 |
AIM ImmunoTech Inc | 0.24 |
IGC Pharma Inc | 0.3811 |
NovaBay Pharmaceuticals Inc | 0.7801 |
Protalix BioTherapeutics Inc | 1.32 |
Price Related Metrics
PS Ratio | 0.0968 |
Earnings Yield | -2.25K% |
Market Cap | 2.895M |